|
시장보고서
상품코드
1915277
Drug Discovery 정보학 시장(2026-2030년)Global Drug Discovery Informatics Market 2026-2030 |
||||||
세계의 Drug Discovery 정보학 시장은 2025-2030년 60억 2,740만 달러 증가하고, 예측 기간 중 연평균 복합 성장률(CAGR)은 12.5%를 나타낼 것으로 예측됩니다. 본 보고서에서는 세계의 Drug Discovery 정보학 시장에 관한 종합적 분석, 시장 규모와 예측, 동향, 성장요인, 과제와 약 25개사 벤더 분석 등의 정보를 제공합니다.
본 보고서는 현재 시장 상황, 최신 동향 및 성장요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 시장 성장은 데이터 기반 신약개발에 대한 수요 증가, 계산생물학의 발전, 제약 및 생명공학 분야의 파이프라인 확장, 아웃소싱 트렌드에 의해 주도되고 있습니다.
이번 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보의 객관적인 조합을 통해 이루어졌습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 수록되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2026년 |
| 종료 연도 | 2030년 |
| 예측 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| YOY 2026 | 11.6% |
| CAGR | 12.5% |
| 증가액 | 60억 2,740만 달러 |
이 보고서는 향후 몇 년간 세계 신약개발 정보학 시장의 성장을 견인할 주요 요인 중 하나로 AI와 머신러닝(ML)의 정보학 플랫폼으로의 통합을 꼽았습니다. 또한, 클라우드 기반 신약개발정보학 솔루션의 도입 확대와 통합형 엔드투엔드 신약개발정보학 플랫폼에 대한 관심이 높아짐에 따라 시장에서 상당한 수요가 발생할 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
- 시장 생태계
- 시장 특징
- 밸류체인 분석
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2025년)
- 시장 전망(2025-2030년)
제5장 시장 규모 실적
- 세계의 Drug Discovery 정보학 시장(2020-2024년)
- 용도별 분석(2020-2024년)
- 솔루션별 분석(2020-2024년)
- 최종사용자별 분석(2020-2024년)
- 지역별 분석(2020-2024년)
- 국가별 분석(2020-2024년)
제6장 정성 분석
- AI가 가져오는 영향 - 세계 Drug Discovery 정보학 시장
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 용도별
- 비교 : 용도별
- Drug Discovery 정보학
- 개발 정보학
- 시장 기회 : 용도별
제9장 시장 세분화 : 솔루션별
- 비교 : 솔루션별
- 소프트웨어
- 서비스
- 시장 기회 : 솔루션별
제10장 시장 세분화 : 최종사용자별
- 비교 : 최종사용자별
- 제약 기업 및 바이오테크놀러지 기업
- 수탁연구기관
- 학술연구기관
- 시장 기회 : 최종사용자별
제11장 고객 상황
제12장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 아시아
- 중국
- 일본
- 인도
- 한국
- 태국
- 인도네시아
- 세계 기타 지역
- 브라질
- 이스라엘
- 사우디아라비아
- 아랍에미리트(UAE)
- 아르헨티나
- 남아프리카공화국
- 튀르키예
- 콜롬비아
- 시장 기회 : 지역별
제13장 촉진요인·과제·기회
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회
제14장 경쟁 구도
- 개요
- 경쟁 구도
- 파괴적 혁신 상황
- 업계 리스크
제15장 경쟁 분석
- 기업 개요
- 기업 순위 지표
- 기업의 시장 포지셔닝
- Certara Inc.
- Charles River Laboratories
- Collaborative Drug Discovery
- Cresset Biomolecular Ltd.
- Dassault Systemes SE
- Dotmatics
- Evotec SE
- IBM Corp.
- Jubilant Pharmova Ltd.
- LabVantage Solutions Inc.
- OpenEye Scientific
- Revvity Inc.
- Schrodinger Inc.
- Selvita SA
- Thermo Fisher Scientific Inc.
제16장 부록
LSHThe global drug discovery informatics market is forecasted to grow by USD 6027.4 mn during 2025-2030, accelerating at a CAGR of 12.5% during the forecast period. The report on the global drug discovery informatics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for data-driven drug discovery, advancements in computational biology, expanding pharmaceutical and biotechnology pipelines and outsourcing trends.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 11.6% |
| CAGR | 12.5% |
| Incremental Value | $6027.4 mn |
Technavio's global drug discovery informatics market is segmented as below:
By Application
- Discovery informatics
- Development informatics
By Solution
- Software
- Services
By End-User
- Pharma and biotech companies
- Contract research organizations
- Academic and research institutes
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of AI and ML into informatics platforms as one of the prime reasons driving the global drug discovery informatics market growth during the next few years. Also, growing adoption of cloud-based drug discovery informatics solutions and increased focus on integrated end-to-end discovery informatics platforms will lead to sizable demand in the market.
The report on the global drug discovery informatics market covers the following areas:
- Global drug discovery informatics market sizing
- Global drug discovery informatics market forecast
- Global drug discovery informatics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global drug discovery informatics market vendors that include Accenture PLC, Certara Inc., Charles River Laboratories, Collaborative Drug Discovery, Cresset Biomolecular Ltd., Curia Global Inc., Dassault Systemes SE, Dotmatics, Eurofins Scientific SE, Evotec SE, IBM Corp., Jubilant Pharmova Ltd., LabVantage Solutions Inc., OpenEye Scientific, Revvity Inc., Schrodinger Inc., Selvita SA, Thermo Fisher Scientific Inc.. Also, the global drug discovery informatics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Solution
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Drug Discovery Informatics Market 2020 - 2024
- Historic Market Size - Data Table on Global Drug Discovery Informatics Market 2020 - 2024 ($ million)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.3 Solution segment analysis 2020 - 2024
- Historic Market Size - Solution Segment 2020 - 2024 ($ million)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 The Impact of AI on Global Drug Discovery Informatics Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Discovery informatics - Market size and forecast 2025-2030
- 8.4 Development informatics - Market size and forecast 2025-2030
- 8.5 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by Solution
- 9.1 Market segments
- 9.2 Comparison by Solution
- 9.3 Software - Market size and forecast 2025-2030
- 9.4 Services - Market size and forecast 2025-2030
- 9.5 Market opportunity by Solution
- Market opportunity by Solution ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Pharma and biotech companies - Market size and forecast 2025-2030
- 10.4 Contract research organizations - Market size and forecast 2025-2030
- 10.5 Academic and research institutes - Market size and forecast 2025-2030
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Thailand - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Israel - Market size and forecast 2025-2030
- 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.4 UAE - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.6.7 Turkey - Market size and forecast 2025-2030
- 12.6.8 Colombia - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising demand for data-driven drug discovery
- Advancements in computational biology
- Expanding pharmaceutical and biotechnology pipelines and outsourcing trends
- 13.2 Market challenges
- High implementation costs and budget constraints in research organizations
- Data integration complexity and interoperability issues
- Data security and intellectual property protection risks
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of AI and ML into informatics platforms
- Growing adoption of cloud-based drug discovery informatics solutions
- Increased focus on integrated end-to-end discovery informatics platforms
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Certara Inc.
- Certara Inc. - Overview
- Certara Inc. - Business segments
- Certara Inc. - Key offerings
- Certara Inc. - Segment focus
- SWOT
- 15.5 Charles River Laboratories
- Charles River Laboratories - Overview
- Charles River Laboratories - Business segments
- Charles River Laboratories - Key offerings
- Charles River Laboratories - Segment focus
- SWOT
- 15.6 Collaborative Drug Discovery
- Collaborative Drug Discovery - Overview
- Collaborative Drug Discovery - Product / Service
- Collaborative Drug Discovery - Key offerings
- SWOT
- 15.7 Cresset Biomolecular Ltd.
- Cresset Biomolecular Ltd. - Overview
- Cresset Biomolecular Ltd. - Product / Service
- Cresset Biomolecular Ltd. - Key offerings
- SWOT
- 15.8 Dassault Systemes SE
- Dassault Systemes SE - Overview
- Dassault Systemes SE - Business segments
- Dassault Systemes SE - Key news
- Dassault Systemes SE - Key offerings
- Dassault Systemes SE - Segment focus
- SWOT
- 15.9 Dotmatics
- Dotmatics - Overview
- Dotmatics - Product / Service
- Dotmatics - Key offerings
- SWOT
- 15.10 Evotec SE
- Evotec SE - Overview
- Evotec SE - Business segments
- Evotec SE - Key news
- Evotec SE - Key offerings
- Evotec SE - Segment focus
- SWOT
- 15.11 IBM Corp.
- IBM Corp. - Overview
- IBM Corp. - Business segments
- IBM Corp. - Key news
- IBM Corp. - Key offerings
- IBM Corp. - Segment focus
- SWOT
- 15.12 Jubilant Pharmova Ltd.
- Jubilant Pharmova Ltd. - Overview
- Jubilant Pharmova Ltd. - Business segments
- Jubilant Pharmova Ltd. - Key offerings
- Jubilant Pharmova Ltd. - Segment focus
- SWOT
- 15.13 LabVantage Solutions Inc.
- LabVantage Solutions Inc. - Overview
- LabVantage Solutions Inc. - Product / Service
- LabVantage Solutions Inc. - Key offerings
- SWOT
- 15.14 OpenEye Scientific
- OpenEye Scientific - Overview
- OpenEye Scientific - Product / Service
- OpenEye Scientific - Key offerings
- SWOT
- 15.15 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 15.16 Schrodinger Inc.
- Schrodinger Inc. - Overview
- Schrodinger Inc. - Business segments
- Schrodinger Inc. - Key offerings
- Schrodinger Inc. - Segment focus
- SWOT
- 15.17 Selvita SA
- Selvita SA - Overview
- Selvita SA - Business segments
- Selvita SA - Key offerings
- Selvita SA - Segment focus
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
